Clinical Signficance of p53, Proliferating Cell Nuclear Antigen and bcl-2 Expression in Bladder Transitional Cell Carcinoma

By Zhu Zhaohui   Cheng Ping   Zeng Fuqing   Lu Gongcheng   Xing Shian  

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 20-23

Springer Publishing Company

Access to resources Recommend Favorite

Expression of epithelial cell adhesion molecule and proliferating cell nuclear antigen in diethylnitrosamineinduced hepatocarcinogenesis in mice

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 1, 2013-01 ,pp. : 138-142

Spandidos Publications

Access to resources Recommend Favorite

Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen

By Xu Wei  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 63-69

Springer Publishing Company

Access to resources Recommend Favorite

Proliferating cell nuclear antigen and heat shock protein 70 immuno-localization in invasive ductal breast cancer not otherwise specified

By Lazaris A.C.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 43-51

Springer Publishing Company

Access to resources Recommend Favorite

Proliferating Cell Nuclear Antigen in Endometrial Carcinoma: Pretreatment Identification of High-Risk Patients

By Garzetti G.G.   Ciavattini A.   Goteri G.   de Nictolis M.   Romanini C.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 16-21

Academic Press

Access to resources Recommend Favorite